Alpine Global Management LLC bought a new stake in Ambrx Biopharma during the fourth quarter worth about $106,000.

Source: https://www.americanbankingnews.com/2023/09/21/cormorant-asset-management-lp-buys-751233-shares-of-ambrx-biopharma-inc-nyseamam-stock.html

Ambrx will receive low double-digit tiered royalties on ARX788 sales in China, potentially reaching the "mid-teens range" on aggregate net sales.

Source: https://seekingalpha.com/article/4630009-promising-developments-in-ambrxs-engineered-precision-biologics?source=feed_all_articles

On Monday, April 17th, Cormorant Asset Management, Lp bought 562,121 shares of Ambrx Biopharma stock.

Source: https://www.dailypolitical.com/2023/04/20/insider-buying-ambrx-biopharma-inc-nyseamam-major-shareholder-purchases-951909-shares-of-stock.html